United States· US:51672-1396_39702ff5-c8de-79c1-e063-6294a90a6dfa
Desoximetasone
A medicinal product containing desoximetasone, registered in United States by Sun Pharmaceutical Industries, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DESOXIMETASONE
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc1151672139631 BOTTLE, SPRAY in 1 CARTON (51672-1396-3) / 30 mL in 1 BOTTLE, SPRAY
- ndc1151672139641 BOTTLE, SPRAY in 1 CARTON (51672-1396-4) / 50 mL in 1 BOTTLE, SPRAY
- ndc1151672139662 BOTTLE, SPRAY in 1 CARTON (51672-1396-6) / 50 mL in 1 BOTTLE, SPRAY
- ndc1151672139671 BOTTLE, SPRAY in 1 CARTON (51672-1396-7) / 100 mL in 1 BOTTLE, SPRAY
- ndc1151672-1396-3
- ndc1151672-1396-4
- ndc1151672-1396-6
- ndc1151672-1396-7
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Desoximetasone in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaTOPICORTBAUSCH HEALTH, CANADA INC.
- FinlandIbarilAventis Pharma Deutschland GmbH
- NetherlandsDesoximetason Bipharma 2,5 mg/g, hydrofobe crèmeBipharma B.V.
- NorwayDesoximetason bipharmaBipharma
- United KingdomStiedex LP 0.05% oily creamStiefel Laboratories (UK) Ltd
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Italy · Flubason
- Netherlands · Desoximetason Bipharma, Topicorte
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ddacf89d-03f0-49d9-a9d9-6f502758ef5d GET /v1/drugs/ddacf89d-03f0-49d9-a9d9-6f502758ef5d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "2.5",
"substance": "DESOXIMETASONE",
"productndc": "51672-1396",
"dosage_form": "SPRAY",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA204141",
"marketing_category": "NDA AUTHORIZED GENERIC"
}See everything about desoximetasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.